JAK2 and essential thrombocythemia: The presence of JAK2 (p < 0.05 and p < 0.001, respectively) or CALR mutations (p < 0.05 and p < 0.01, respectively) was linked with reduced MKMVs and increased concentrations of PLTMVs in ET versus controls and in ET versus triple-negative subjects, respectively.